Back to search

Article

In vitro evaluation of factor IX as novel treatment for factor XI deficiency

2019-04-19

Abstract excerpt

<h4>ABSTRACT</h4> Factor XI deficiency is associated with mild to moderate bleeding upon injury. Treatment of bleeding in patients can be a challenge due to the limited availability of factor XI concentrates that may also have thrombotic side effects, and the volume overload as a result of plasma transfusion. In our in vitro study, we established that recombinant factor IX concentrate Benefix® (Pfizer) was able t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
47b4574e-ec3a-5662-89b0-6c4559d0d902
DOI
10.1101/614180
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In vitro evaluation of factor IX as novel treatment for factor XI deficiencyDOI 10.1101/614180
Select a neighboring publication to make it the new centre.